Forensic Genomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The forensic genomics market is expected to increase from USD 0.66 billion in 2025 to USD 0.74 billion in 2026 and reach USD 1.50 billion by 2031, growing at a CAGR of 15.17% over 2026-2031. This report is Segmented by Product Type (Instruments, Kits and Consumables, Software and Services), Method (Next-Generation Sequencing, Capillary Electrophoresis, and More), Therapeutic Area (Paternity and Familial Testing, Human Identification, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Forensic Genomics Market Trends and Insights

Advancements in Next-Generation Sequencing (NGS) for Complex Forensic DNA Analysis

Next-generation sequencing moved into a lead position in 2025, with more than half of the forensic genomics market tied to this method by revenue. This marks a clear change from the older pattern where capillary electrophoresis defined most routine forensic DNA work. A 2025 peer-reviewed study showed that sequencing 26 autosomal STR loci reduced random match probability by more than 700 times compared with conventional CE-STR analysis, and flanking region variation improved discrimination further.That performance matters in the forensic genomics market because mixed samples, low template samples, and degraded remains remain common in actual investigations and identification work. QIAGEN’s ForenSeq Kintelligence HT Kit reflects the same shift, because it is built around 10,230 SNP markers for kinship work and degraded skeletal remains, which shows that vendors are designing products for the hardest cases rather than only for routine workflows. The forensic genomics market is therefore moving toward platforms that combine stronger discrimination, broader sample compatibility, and richer evidentiary output, even though laboratories still need more dedicated bioinformatics support before this transition can scale fully.

Expansion of National DNA Databases and Kinship Matching Programs

The forensic genomics market is closely linked to the continuing expansion of national DNA databases, because each additional profile makes the value of database participation more visible to law enforcement agencies and public funders. FBI statistics for late 2025 showed that NDIS stored more than 24.8 million offender DNA profiles and had aided more than 758,449 investigations, which keeps the case for continued spending on kits, instruments, and lab processing capacity firmly in place. In the United States, the CODIS Access Modernization Act would allow eligible private forensic laboratories to upload qualifying DNA profiles directly to NDIS, which would broaden the commercial base beyond public sector labs if adopted. As more countries tighten operating rules around chain of custody, validation, and upload quality, the forensic genomics market gains volume, while established suppliers gain an advantage because their systems are better positioned to meet formal standards.

High Capital and Validation Cost of Sequencers and Reference Workflows

The forensic genomics market still faces a meaningful access barrier because capital requirements remain high for both equipment and compliance. Rapid DNA systems alone carry an instrument price near USD 250,000, and laboratories that shift into next-generation sequencing must also fund supporting software, data storage, and validation work before they can use new workflows in casework. The cost burden therefore reaches beyond instrument purchase and extends into training, documentation, data handling, and the time laboratories lose while new workflows are being qualified. The forensic genomics market can continue to grow under those conditions, but adoption will remain uneven where laboratories have limited budgets or where new capacity is still being built from the ground up.

Other drivers and restraints analyzed in the detailed report include:

• Growth in Rapid DNA and Portable Sequencing Adoption in Field Workflows
• Increasing Adoption of Forensic DNA Phenotyping and Investigative Genetic Genealogy
• Cross-Border Data Governance and Privacy Constraints on DNA Data Sharing

Segment Analysis

Instruments accounted for 47.92% of the forensic genomics market size in 2025, which reflects the central role of capillary electrophoresis platforms and the growing installed base of sequencing systems in routine laboratory operations. This segment remains foundational because every accredited workflow depends on validated hardware before evidence can move into interpretation or reporting. The installed base also creates long replacement cycles, which gives the forensic genomics market a durable equipment layer with steady recurring demand for consumables, service contracts, and workflow upgrades. In the forensic genomics industry, that pattern supports established vendors whose products are already embedded in laboratory standard operating procedures.

Software and services are projected to record the fastest growth at a 17.14% CAGR through 2031, which shows that value creation in the forensic genomics market is moving toward analysis and interpretation as workflows become more data-intensive. This shift is tied to probabilistic genotyping, cloud-capable laboratory information systems, and specialist genealogy or kinship tools that address analytical bottlenecks rather than sample extraction alone. The forensic genomics market is therefore seeing competitive strength shift from hardware exclusivity toward the ability to explain mixtures, document interpretation logic, and support secure, auditable workflows.

Complete Report Scope:

• By Product Type
  • Instruments
  • Kits and Consumables
  • Software and Services
• By Method
  • Next-Generation Sequencing
  • Capillary Electrophoresis
  • Polymerase Chain Reaction
  • Other Methods
• By Therapeutic Area
  • Paternity and Familial Testing
  • Human Identification
  • Criminal Investigation & Cold Case Resolution
  • Other Applications
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.57% of the forensic genomics market share in 2025, which kept it in the leading regional position. The region’s advantage comes from the deepest laboratory network, the largest national DNA database, and stable public funding channels that continue to support casework expansion and technology refresh cycles. The proposed CODIS Access Modernization Act could widen the commercial base further by allowing eligible private laboratories to upload qualifying profiles directly to NDIS, which would expand demand beyond traditional public laboratories if enacted.

Europe remains the second-largest regional block in the forensic genomics market, supported by strong accreditation discipline and a mature operational culture in countries such as Germany, the United Kingdom, and France. The region’s laboratories operate within a framework that places heavy weight on validation quality, proficiency testing, and interoperability across established DNA comparison systems. This keeps demand focused on standards-compliant kits and auditable software rather than on low-cost, lightly validated alternatives. Privacy rules also influence product design in the forensic genomics market, because vendors need workflows that support controlled access, secure handling, and defensible use of sensitive genetic data. As a result, Europe remains a high-quality revenue region where procurement is often driven by regulatory fit as much as by raw instrument performance.

Asia-Pacific is the fastest-growing region, with the forensic genomics market for the region projected to grow at an 18.21% CAGR through 2031. China is a major force behind that pace because a series of national forensic DNA standards that became effective from 2024 onward created a formal procurement path for laboratory construction, examination specifications, and NGS-based DNA examination. Japan’s revised DNA profiling guidance adds another layer of demand discipline by updating requirements for national database submissions. South Korea and Australia continue to provide established regional demand, while emerging Southeast Asian markets represent earlier-stage opportunities for future rollout. The recognition of China’s integrated one-hour forensic DNA detection system in 2026 also suggests that domestic innovation is becoming a more active force in the regional forensic genomics market, especially in field-deployable formats.

List of Companies Covered in this Report:

• Agilent Technologies
• Bio-Rad Laboratories
• Bode Technology Group, Inc.
• Eurofins
• Gene by Gene, Ltd.
• Hamilton Company
• Illumina
• InnoGenomics Technologies, LLC
• LGC Group
• MGI Tech Co., Ltd.
• Neogen
• NicheVision Forensics, LLC
• Othram, Inc.
• Parabon NanoLabs, Inc.
• Promega
• QIAGEN
• Sorenson Forensics, LLC
• Thermo Fisher Scientific
• Tri Tech Forensics, Inc.
• Verogen, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support